Updated Date: Wed, 29 Mar 2023 00:00:00 EDT
Category: Uncategorized
Updated Date: Wed, 29 Mar 2023 00:00:00 EDT
Updated Date: Wed, 29 Mar 2023 00:00:00 EDT
Updated Date: Wed, 29 Mar 2023 00:00:00 EDT
Company disappointed by institute’s failure to recommend thyroid cancer therapy for specific patient group
Individual receives AVA6000 treatment as part of additional dose escalating study
Study becomes the first-in-human clinical trial involving OMX-0407 in a specific patient group
Funds will be used to ensure the wider pan-sarcoma development of lead candidate uPARAP
Updated Date: Mon, 27 Mar 2023 00:00:00 EDT